M. Huguet

发表

Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.

A. Serre, S. Bascoul, A. Cannat, 1978, Immunology.

Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells.

M. Zembala, C. Alix-Panabières, V. Baillat, 2002, Clinical immunology.

Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay.

G. Petitjean, P. Blanc, J. Ducos, 2006, Journal of immunological methods.

In-vitro synthesis of antibodies to Toxoplasma gondii by lymphocytes from HIV-1-infected patients

F. Pratlong, M. Segondy, J. Reynes, 1993, The Lancet.

Virus isolation, polymerase chain reaction and in vitro antibody production for the diagnosis of pediatric human immunodeficiency virus infection.

J. Nicolas, M. Segondy, E. Grimprel, 1993, Journal of virological methods.

Cytokines and Cell Surface Molecules Independently Induce CXCR4 Expression on CD4+ CCR7+ Human Memory T Cells1

H. Yssel, J. Bousquet, M. Segondy, 2000, The Journal of Immunology.

Human Memory T Cells + CCR 7 + CD 4 Independently Induce CXCR 4 Expression on Cytokines and Cell Surface Molecules

J. Bousquet, H. Yssel, M. Segondy, 2000 .

Spontaneous in vitro anti-human immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults.

J. Ducos, J. Reynes, M. Huguet, 1994, The Journal of infectious diseases.

Cytomegalovirus-specific B cell activation as a potential marker for the diagnosis of cytomegalovirus infection

J. Nicolas, B. Albat, M. Segondy, 1990, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro studies on the adjuvanticity of Brucella fractions

A. Serre, A. Cannat, M. Huguet, 1982, Infection and immunity.

Mitogenic activity of two Brucella fractions for murine B lymphocytes.

A. Serre, A. Cannat, M. Huguet, 1980, Immunology.

Biological properties of a panel of murine monoclonal anti-Brucella antibodies.

F. Peraldi, A. Serre, A. Cannat, 1987, Immunology.

Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy

H. Yssel, P. Van de Perre, V. Baillat, 2003, AIDS.

Dynamics of spontaneous HIV-1 specific and non-specific B-cell responses in patients receiving antiretroviral therapy

M. Segondy, C. Alix-Panabières, V. Baillat, 2002, AIDS.

Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk.

G. Petitjean, P. Van de Perre, N. Meda, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Detection of a large T-cell reservoir able to replicate HIV-1 actively in breast milk

G. Petitjean, P. Van de Perre, N. Meda, 2006, AIDS.

Detection and enumeration of HIV-1-producing cells by ELISPOT (enzyme-linked immunospot) assay.

L. Briant, M. Segondy, J. Reynes, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Brucella fractions behave as nonspecific mitogens and polyclonal B-cell activators for human lymphocytes

A. Serre, A. Cannat, M. Huguet, 1985, Infection and immunity.

Spontaneous in vitro secretion of antibody to cytomegalovirus (CMV) by human peripheral blood mononuclear cells: a new approach to studying the CMV-immune system interaction.

M. Segondy, J. Ducos, J. Reynes, 1991, The Journal of infectious diseases.

SPECIFICITIES OF HIV-1 ANTIBODIES IN SERUM AND IN PERIPHERAL BLOOD SUPERNATANTS

J. Ducos, J. Reynes, A. Cannat, 1989, The Lancet.

Spontaneous monoclonal immunoglobulin‐secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma

J. Rossi, T. Lavabre‐Bertrand, M. Huguet, 2000, British journal of haematology.

In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humans

M. Segondy, M. Huguet, A. Bertrand, 1992, Journal of clinical microbiology.

Cytomegalovirus‐specific in vitro antibody production by peripheral blood lymphocytes from renal transplant recipients with CMV infection

M. Segondy, M. Huguet, J. Vendrell, 1993, Journal of medical virology.

Analysis of the spontaneous in vitro anti‐HIV‐1 antibody secretion by peripheral blood mononuclear cells in HIV‐1 infection

M. Segondy, J. Ducos, J. Reynes, 1991, Clinical and experimental immunology.

IN-VITRO SECRETION OF HIV-SPECIFIC ANTIBODIES BY PERIPHERAL BLOOD CELLS

J. Reynes, P. Corbeau, A. Cannat, 1988, The Lancet.

Detection and Enumeration of Circulating HIV-1–Specific Memory B Cells in HIV-1–Infected Patients

V. Baillat, J. Reynes, M. Huguet, 2004, Journal of acquired immune deficiency syndromes.

Secretion of Toxoplasma gondii‐specfic antibody in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosis

F. Pratlong, M. Segondy, M. Huguet, 1992, Clinical and experimental immunology.

Interpreting western blot indeterminate HIV antibody tests

J. Ducos, M. Segondy, M. Huguet, 1990, The Lancet.

Human Immunodeficiency Virus Type 1 (HIV-1) Antigen Secretion by Latently Infected Resting CD4+ T Lymphocytes from HIV-1-Infected Individuals

G. Petitjean, P. Becquart, V. Baillat, 2004, Journal of Virology.

Human Immunodeficiency Virus Type 1 ( HIV-1 ) Antigen Secretion by Latently Infected Resting CD 4 T Lymphocytes from HIV-1-Infected Individuals

G. Petitjean, P. Becquart, V. Baillat, 2004 .

CD4 masking during human immunodeficiency virus type 1 infection, quantified on peripheral blood lymphocytes, is a potential marker of disease progression.

P. Gros, B. Pau, J. Reynes, 1996, The Journal of infectious diseases.